185
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Effects of hypertension and FAAH inhibitor treatment of rats with primary and secondary hypertension considering the physicochemical properties of erythrocytes

, , , &
Pages 297-305 | Received 08 Aug 2019, Accepted 05 Feb 2020, Published online: 20 Feb 2020

References

  • Anand-Srivastava M.B. 2010. Modulation of Gi proteins in hypertension: role of angiotensin II and oxidative stress. Curr Cardiol Rev. 6(4):298–308.
  • Baranowska-Kuczko M, Kozłowska H, Kloza M, Karpińska O, Toczek M, Harasim E, Kasacka I, Malinowska B. 2016. Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats. Life Sci. 151:288–299.
  • Biernacki M, Ambrożewicz E, Gęgotek A, Toczek M, Bielawska K, Skrzydlewska E. 2018. Redox system and phospholipid metabolism in the kidney of hypertensive rats after FAAH inhibitor URB597 administration. Redox Biol. 15:41–50.
  • Biernacki M, Ambrożewicz E, Gęgotek A, Toczek M, Skrzydlewska E. 2019. Long-term administration of fatty acid amide hydrolase inhibitor (URB597) to rats with spontaneous hypertension disturbs liver redox balance and phospholipid metabolism. Adv Med Sci. 64(1):15–23.
  • Biernacki M, Łuczaj W, Gęgotek A, Toczek M, Bielawska K, Skrzydlewska E. 2016. Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats. Toxicol Appl Pharmacol. 301:31–41.
  • Biernacki M, Łuczaj W, Jarocka-Karpowicz I, Ambrożewicz E, Toczek M, Skrzydlewska E. 2018. The effect of long-term administration of fatty acid amide hydrolase inhibitor urb597 on oxidative metabolism in the heart of rats with primary and secondary hypertension. Molecules. 14. 23:32.
  • Biernacki M, Malinowska B, Timoszuk M, Toczek M, Jastrząb A, Remiszewski P, Skrzydlewska E. 2018. Hypertension and chronic inhibition of endocannabinoid degradation modify the endocannabinoid system and redox balance in rat heart and plasma. Prostag Oth Lipid M. 138:54–63.
  • Briones AM, Touyz RM. 2010. Oxidative stress and hypertension: current concepts. Curr Hypertens Rep. 12(2):135–142.
  • Cerecedo D, Martinez-Vieyra I, Sosa-Peinado A, Cornejo-Garrido J, Ordaz-Pichado C, Benitez-Cardoza C. 2016. Alterations in plasma membrane promote overexpression and increase of sodium influx through epithelial sodium channel in hypertensive platelets. Biochim Biophys Acta. 1858(8):1891–1903.
  • Chiarini A, Fiorilli A, Di Francesco L, Venerando B, Tettamanti G. 1993. Human erythrocyte sialidase is linked to the plasma membrane by a glycosylphosphatidylinositol anchor and partly located on the outer surface. Glycoconjugate J. 10(1):64–71.
  • Crowley SD. 2014. The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension. Antioxid Redox Sign. 20(1):102–120.
  • David-Dufilho M, Astarie C, Pernollet MG, Del-Pino M, Levenson J, Simon A, Devynck MA. 1992. Control of the erythrocyte free Ca21 concentration in essentials hypertension. Hypertension. 19(2):167–174.
  • Delannoya M, Del Balzoa G, Filippinic F, D´Arrigoa M, Riquelmea B. 2012. Arterial hypertension modeled by in vitro treatment of red blood cells with trypsin. Series Biomech. 27:87–92.
  • Dobrzyńska I, Skrzydlewska E, Figaszewski Z. 2006. Parameters characterizing acid-base equilibria between cell membrane and solution and their application to monitoring the effect of various factors on the membrane. Bioelectrochemistry. 69:142–147.
  • Dobrzyńska I, Szachowicz-Petelska B, Ostrowska J, Skrzydlewska E, Figaszewski ZA. 2005. Protective effect of green tea on erythrocyte membrane of different age rats intoxicated with ethanol. Chem Biol Interact. 156(1):41–53.
  • Dobrzyńska I, Szachowicz-Petelska B, Skrzydlewska E, Figaszewski ZA. 2013. Effect of sweet grass (Hierochloe odorata) on the physico-chemical properties of liver cell membranes from rats intoxicated with ethanol. Environ Toxicol Pharm. 35(2):247–253.
  • Dobrzyńska I, Szachowicz-Petelska B, Weresa J, Figaszewski ZA, Skrzydlewska E. 2019. Changes in physicochemical properties of kidney cells membrane as a consequence of hypertension and treatment of hypertensive rats with FAAH inhibitor. Chem Biol Interact. 299:52–58.
  • Farland MJ, Porter AC, Rakhshan FR, Rawat DS, Gibbs RA. 2004. A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide. J Biol Chem. 279:41991–41997.
  • Folch J, Lees M, Stanley G. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 226(1):497–509.
  • Godlewski G, Alapafuja SO, Bátkai S, Nikas SP, Cinar R, Offertáler L, Osei-Hyiaman D, Liu J, Mukhopadhyay B, Harvey-White J, et al. 2010. Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects. Chem Biol. 17(11):1256–1266.
  • Hadengue AL, Del-Pino M, Simon A, Levenson J. 1998. Erythrocyte disaggregation shear stress, sialic acid, and cell aging in humans. Hypertension. 32(2):324–330.
  • Harasim-Symbor E, Polak A, Pędzińska-Betiuk A, Weresa J, Malinowska B, Lewandowska A, Kasacka I, Chabowski A. 2019. Fatty acid amide hydrolase inhibitor (URB597) as a regulator of myocardial lipid metabolism in spontaneously hypertensive rats. Chem Phys Lipids. 218:141–148.
  • Jourdian GW, Dean L, Roseman S. 1971. The sialic acids. XI. A periodate-resorcinol method for the quantitative estimation of free sialic acids and their glycosides. J Biol Chem. 246(2):430–435.
  • Kasap S, Gönenç A, Şener D E, Hisar İ. 2007. Serum cardiac markers in patients with acute myocardial infarction: oxidative stress, C-reactive protein and N-terminal probrain natriuretic peptide. J Clin Biochem Nutr. 41(1):50–57.
  • Kinsey SG, Naidu PS, Cravatt BF, Dudley DT, Lichtman AH. 2011. Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice. Pharmacol Biochem Behav. 99(4):718–725.
  • Kloza M, Baranowska-Kuczko M, Malinowska B, Karpińska O, Harasim-Symbor E, Kasacka I, Kozłowska H. 2017. The influence of DOCA-salt hypertension and chronic administration of the FAAH inhibitor URB597 on KCa2.3/KCa3.1-EDH-type relaxation in rat small mesenteric arteries. Vascul Pharmacol. 99:65–73.
  • Konstantinowa E, Ivanova L, Tolstaya T, Mironowa E. 2006. Rheological properties of blood and parameters of platelets aggregation in arterial hypertension. Clin Hemorheol Microcirc. 35:135–138.
  • Lerman LO, Nath KA, Rodriguez-Porcel M, Krier JD, Schwartz RS, Napoli C, Romero JC. 2001. Increased oxidative stress in experimental renovascular hypertension. Hypertension. 37(2):541–546.
  • Li Z, Liu J, Shen Y, Zeng F, Zheng D. 2016. Increased Lipoprotein-associated phospholipase A2 activity portends an increased risk of resistant hypertension. Lipids Health Dis. 15(1):15.
  • Liu J, Kennedy DJ, Yan Y, Shapiro JI. 2012. Reactive oxygen species modulation of Na/K-ATPase regulates fibrosis and renal proximal tubular sodium handling. Int J Nephrol. 2012:1–14..
  • Luo WM, Kong J, Gong Y, Liu XQ, Yang RX, Zhao YX. 2015. Tongxinluo protects against hypertensive kidney injury in spontaneously-hypertensive rats by inhibiting oxidative stress and activating forkhead Box O1 signaling. PLOS One. 10(12):e0145130.
  • Luo XP, Yazdanpanah M, Bhooi N, Lehotay DC. 1995. Determination of aldehydes and other lipid peroxidation products in biological samples by gas chromatography-mass spectrometry. Anal Biochem. 228(2):294–298.
  • Martín Giménez VM, Noriega SE, Kassuha DE, Fuentes LB, Manucha W. 2018. Anandamide and endocannabinoid system: an attractive therapeutic approach for cardiovascular disease. Ther Adv Cardiovasc Dis. 12(7):177–190.
  • Murphy N, Cowley TR, Blau CW, Dempsey CN, Noonan J, Gowran A, Tanveer R, Olango WM, Finn DP, Campbell VA, et al. 2012. The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation. J Neuroinflammation. 9:79.
  • Polak A, Harasim E, Chabowski A. 2016. Effects of activation of endocannabinoid system on myocardial metabolism. Postepy Hig Med Dosw. 70:542–555.
  • Polak A, Harasim-Symbor E, Malinowska B, Kasacka I, Lewandowska A, Chabowski A. 2018. The endocannabinoid system affects myocardial glucose metabolism in the DOCA-salt model of hypertension. Cell Physiol Biochem. 46(2):727–739.
  • Radosińska J, Vrbjar N. 2016. The role of red blood cell deformability and Na,K-ATPase function in selected risk factors of cardiovascular diseases in humans: focus on hypertension, diabetes mellitus and hypercholesterolemia. Physiol Res. 65(1):S43–S54.
  • Reis A, Spickett CM. 2012. Chemistry of phospholipid oxidation. Biochim Biophys Acta-Biomembr. 1818(10):2374–2387.
  • Shulaev V, Oliver DJ. 2006. Metabolic and proteomic markers for oxidative stress. New tools for reactive oxygen species research. Plant Physiol. 141(2):367–372.
  • Szachowicz-Petelska B, Dobrzyńska I, Skrzydlewska E, Figaszewski Z. 2008. Changes in phospholipids composition studied by HPLC and electric properties of liver cell membrane of ethanol-poisoned rats. Toxicol Mech Method. 18(6):525–530.
  • Tabet F, Savoia C, Schiffrin EL, Touyz RM. 2004. Differential calcium regulation by hydrogen peroxide and superoxide in vascular smooth muscle cells from spontaneously hypertensive rats. J Cardiovasc Pharmacol. 44(2):200–208.
  • Toczek M, Baranowska-Kuczko M, Grzęda E, Pędzińska-Betiuk A, Weresa J, Malinowska B. 2016. Age-specific influences of chronic administration of the fatty acid amide hydrolase inhibitor URB597 on cardiovascular parameters and organ hypertrophy in DOCA-salt hypertensive rats. Pharmacol Rep. 68(2):363–369.
  • Touyz RM. 2000. Oxidative stress and vascular damage in hypertension. Current Science Inc. 2(1):98–105.
  • Tyurina YY, Shvedova AA, Kawai K, Tyurin VA, Kommineni C, Quinn PJ, Schor NF, Fabisiak JP, Kagan VE. 2000. Phospholipids sygnaling in apoptosis: peroxidation and externalizotion of phosphatidylserine. Toxicology. 148(2–3):93–101.
  • Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, et al. 2004. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries: case-control study. Lancet. 364(9438):937–952.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.